Edition:
United Kingdom

Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS)

600566.SS on Shanghai Stock Exchange

41.60CNY
14 Feb 2018
Change (% chg)

¥0.76 (+1.86%)
Prev Close
¥40.84
Open
¥41.15
Day's High
¥41.97
Day's Low
¥41.00
Volume
2,841,709
Avg. Vol
4,108,602
52-wk High
¥44.00
52-wk Low
¥29.41

Latest Key Developments (Source: Significant Developments)

Hubei Jumpcan Pharmaceutical unit receives GMP certificate
Thursday, 11 Jan 2018 

Jan 11 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Shaanxi Food and Drug Administration .Certificate issued to unit's products including troche, hard capsule and granula .Valid period is until Dec. 27, 2022.  Full Article

Hubei Jumpcan Pharmaceutical unit receives GMP certificate
Tuesday, 2 Jan 2018 

Jan 2(Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says its wholly owned unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration.Says the valid period is until Dec. 25, 2022.  Full Article

Hubei Jumpcan Pharmaceutical's shareholder to cut stake in the company
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>::SAYS SHAREHOLDER PLANS TO UNLOAD ENTIRE HOLDINGS OF 2.65 PERCENT STAKE IN THE COMPANY WITHIN SIX MONTHS.  Full Article

Hubei Jumpcan Pharmaceutical issues 843.2 mln yuan convertible corporate bonds
Friday, 17 Nov 2017 

Nov 17(Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says it issued 843.2 million yuan convertible corporate bonds.Previous news was disclosed on Nov. 8.  Full Article

Hubei Jumpcan Ppharmaceutical's 9-month net profit up 34.2 pct y/y
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says 9-month net profit up 34.2 percent y/y at 907.3 million yuan ($137.77 million).  Full Article

Hubei Jumpcan Pharma's H1 net profit up 33 pct
Monday, 8 Aug 2016 

Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS> :Says H1 net profit up 33.0 percent y/y at 440.4 million yuan ($66.12 million).  Full Article

Hubei Jumpcan Pharmaceutical unit gets approval for drug clinic trial
Monday, 11 Jul 2016 

Hubei Jumpcan Pharmaceutical <600566.SS> Co., Ltd:Says it unit receives drug clinic trial approval from China Food and Drug Administration, for levetiracetam injection.  Full Article

Hubei Jumpcan Pharmaceutical completes private placement of 642.3 mln yuan
Monday, 16 May 2016 

Hubei Jumpcan Pharmaceutical Co., Ltd. <600566.SS> :Says it completes the issue of 28.2 million A shares at 22.8 yuan per share, for 642.3 million yuan via private placement to seven companies.  Full Article

HUBEI JUMPCAN PHARMACEUTICAL amends private placement plan
Thursday, 21 Apr 2016 

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD:Revises private placement plan, which is previously updated on June 30.Revises issue price to 19.59 yuan per share instead of 20.29 yuan per share.  Full Article

HUBEI JUMPCAN PHARMACEUTICAL announces 2015 dividend payment date
Thursday, 14 Apr 2016 

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD:To pay cash dividend of 0.7 yuan per 10 shares (before tax) to shareholders for 2015 as a record of April 19.The company's shares will be traded ex-right and ex-dividend on April 20 and the dividend will be paid on April 20.  Full Article

BRIEF-Hubei Jumpcan Pharmaceutical unit receives GMP certificate

* Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Shaanxi Food and Drug Administration